Use of radiopharmaceuticals for imaging hypoxic tissues [Hipoksik dokularin görüntülenmesinde radyofarmasötiklerin klinik kullanimi]

Basit Öğe Kaydı
dc.contributor.authorÇagliyan O.
dc.contributor.authorAşikoglu M.
dc.date.accessioned2019-10-27T00:25:32Z
dc.date.available2019-10-27T00:25:32Z
dc.date.issued2001
dc.departmentEge Üniversitesien_US
dc.description.abstractHypoxia is the state between oxygen absence and normal oxygenation of the healthy tissue and when the oxygen necessity for normal cell function goes beyond the sources, cells respond to this situation by down-regulating their metabolism. This hypoxic condition is observed in various clinically significant diseases primarily cancer. Tumor hypoxia may increase resistance to radiation therapy and to some forms of chemotherapy. That is why detection of hypoxia is important. Radiolabelled nitroimidazoles, misonidazole analogues, iodoazomycin nucleosides are used for imaging hypoxia.en_US
dc.identifier.endpage100en_US
dc.identifier.issn1300-4182
dc.identifier.issn1300-4182en_US
dc.identifier.issue2en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage93en_US
dc.identifier.urihttps://hdl.handle.net/11454/23264
dc.identifier.volume26en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofFabad Journal of Pharmaceutical Sciencesen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHypoxiaen_US
dc.subjectImagingen_US
dc.subjectRadiopharmaceuticalsen_US
dc.titleUse of radiopharmaceuticals for imaging hypoxic tissues [Hipoksik dokularin görüntülenmesinde radyofarmasötiklerin klinik kullanimi]en_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu